S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)

China Biologic Products (CBPO) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
bbc.com logoChina hits back at Trump with tariffs on $60bn of US goods
bbc.com - December 14 at 8:26 PM
marketwatch.com logoBiologic Excipients industry research covers a wide range of industries with predicted CAGR 10% during 2023-2030
marketwatch.com - June 22 at 6:50 PM
marketwatch.com logoNerve Biologic Products Market 2023-2030: Future Hypothesize and ascending Updates
marketwatch.com - May 6 at 10:45 PM
marketwatch.com logoBiologic Excipients Market by 2030: Future Scope and Predictions
marketwatch.com - April 16 at 8:39 AM
nypost.com logoWhat is the US’ ‘One China’ policy, and why is it important?
nypost.com - April 14 at 8:51 AM
marketwatch.com logoNerve Biologic Products Market in 2023: Insights and Strategies | 2029
marketwatch.com - April 9 at 1:35 PM
marketwatch.com logoBiologic Excipients Market New Innovations and Future Expansion 2023-2028
marketwatch.com - March 8 at 5:19 AM
marketwatch.com logo2023 Nerve Repair and Re-generation Biologic Products Market Future Innovations, Industry Trends and Demand Forecast 2028
marketwatch.com - February 19 at 8:24 PM
yahoo.com logoNeutropenia Biologic Drug Treatment Global Market Report 2023
yahoo.com - February 14 at 2:14 AM
marketwatch.com logoBiologic Imaging Reagents Market is anticipated to shown growth by 2028 |91 Report Pages
marketwatch.com - January 30 at 10:58 AM
yahoo.com logoBiologic Imaging Reagents Market will reach to USD 6.40 billion by 2030 : GreyViews
yahoo.com - January 3 at 3:58 PM
marketwatch.com logoBiologic Injectors Market 2022 Latest Research, Top Impacting Factors, Growth Strategies and Forecast to 2028
marketwatch.com - December 10 at 8:43 AM
ft.com logoChina bars celebrities from endorsing products to boost ‘traditional virtues’
ft.com - November 24 at 11:47 AM
reuters.com logoChina sets oil products export quotas at about 15 million tonnes
reuters.com - October 4 at 9:44 AM
marketwatch.com logoNerve Biologic Products market is projected to grow with magnificent CAGR| Exclusive Report Spread Across 91 Pages
marketwatch.com - September 6 at 10:28 PM
thestreet.com logoBlood Money -- This Plasma Maker Is Set to Soar
thestreet.com - August 12 at 11:01 PM
finance.yahoo.com logoConnect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022
finance.yahoo.com - July 11 at 5:14 PM
finance.yahoo.com logoBiologic API CDMO Benchmarking Report 2022: Comprehensive Analysis of Current Outsourcing Trends and Practices
finance.yahoo.com - June 9 at 12:40 PM
apnews.com logoChina Biologic Privatization Transaction Led by Centurium Capital Wins AVCJ “Deal of the Year - Large Cap”
apnews.com - November 17 at 2:55 AM
finance.yahoo.com logoWere Hedge Funds Right About Silgan Holdings Inc. (SLGN)?
finance.yahoo.com - July 27 at 8:23 PM
Get China Biologic Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

CBPO Media Mentions By Week

CBPO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CBPO
News Sentiment

0.00

0.66

Average
Medical
News Sentiment

CBPO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CBPO Articles
This Week

0

0

CBPO Articles
Average Week

Get China Biologic Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CBPO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners